NNC 38-1049
![]()  | |
| Names | |
|---|---|
| Preferred IUPAC name
 1-(4-Chlorophenyl)-4-(4-cyclopentylpiperazin-1-yl)butane-1,4-dione  | |
| Identifiers | |
CAS Number  | 
|
3D model (JSmol)  | 
|
| ChEMBL | |
| ChemSpider | |
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
InChI 
  | |
SMILES 
  | |
| Properties | |
Chemical formula  | 
C19H25ClN2O2 | 
| Molar mass | 348.866 g/mol | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
NNC 38-1049 is a histamine antagonist selective for the H3 subtype. It has anorectic effects in animal studies and is being researched as a potential treatment for obesity.[1][2]
References
- ↑ Malmlöf K, Zaragoza F, Golozoubova V, et al. (December 2005). "Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight". Int J Obes (Lond). 29 (12): 1402–12. doi:10.1038/sj.ijo.0803036. PMID 16151415.
 - ↑ Malmlöf K, Golozoubova V, Peschke B, Wulff BS, Refsgaard HH, Johansen PB, Cremers T, Rimvall K (Dec 2006). "Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides". Obesity (Silver Spring). 14 (12): 2154–62. doi:10.1038/oby.2006.252. PMID 17189541.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
